The US FDA wants to speed up its policy-making process to better keep up with the speed of scientific advances affecting drug reviews.
Center for Drug Evaluation and Research Director Janet Woodcock said guidances and other policies need to be written faster and more efficiently to ensure drug sponsors receive the most up-to-date...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?